Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion - Wikidata - awgldk - TriplyDB

Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

http://www.wikidata.org/entity/Q36187865

about

Overexpression of Cancer-Associated Genes via Epigenetic Derepression Mechanisms in Gynecologic Cancer Integrating genetics and epigenetics in breast cancer: biological insights, experimental, computational methods and therapeutic potential Impact of Nutrition on Non-Coding RNA Epigenetics in Breast and Gynecological Cancer Role of apoptosis-related miRNAs in resveratrol-induced breast cancer cell death.Effects of genistein supplementation on genome‑wide DNA methylation and gene expression in patients with localized prostate cancer Integrative identification of deregulated miRNA/TF-mediated gene regulatory loops and networks in prostate cancer.Impact of soy isoflavones on the epigenome in cancer prevention.miR-29a activates Hes1 by targeting Nfia in esophageal carcinoma cell line TE-1 The Role of Nutraceuticals in Pancreatic Cancer Prevention and Therapy: Targeting Cellular Signaling, MicroRNAs, and Epigenome.Indole-3-carbinol inhibits tumorigenicity of hepatocellular carcinoma cells via suppression of microRNA-21 and upregulation of phosphatase and tensin homolog.The interaction between epigenetics, nutrition and the development of cancer TRIM68 negatively regulates IFN-β production by degrading TRK fused gene, a novel driver of IFN-β downstream of anti-viral detection systems miR-22 and miR-29a Are Members of the Androgen Receptor Cistrome Modulating LAMC1 and Mcl-1 in Prostate Cancer.Expression levels of JNK associated with polymorphic lactotransferrin haplotypes in human nasopharyngeal carcinoma.Perspectives on the role of isoflavones in prostate cancer.Soy isoflavones and prostate cancer: a review of molecular mechanisms.Epigenetic regulation of miRNA-cancer stem cells nexus by nutraceuticals.Androgen receptor and gene network: Micromechanics reassemble the signaling machinery of TMPRSS2-ERG positive prostate cancer cells.miRNA and TMPRSS2-ERG do not mind their own business in prostate cancer cells.Epigenetic effects of ethanol on the liver and gastrointestinal system.Prostate cancer epigenetic biomarkers: next-generation technologies.The bounty of nature for changing the cancer landscape.Long-term soy consumption and tumor tissue MicroRNA and gene expression in triple-negative breast cancer.Epigenetic and miRNAs Dysregulation in Prostate Cancer: The role of Nutraceuticals.miR-29a suppresses growth and metastasis in papillary thyroid carcinoma by targeting AKT3.Androgen-regulated microRNA-135a decreases prostate cancer cell migration and invasion through downregulating ROCK1 and ROCK2.miR-20a promotes prostate cancer invasion and migration through targeting ABL2.Ameloblastoma RNA profiling uncovers a distinct non-coding RNA signature.miRNA in Prostate Cancer: New Prospects for Old Challenges miRNA and lncRNA as biomarkers in cholangiocarcinoma(CCA).Recent progress on the effects of microRNAs and natural products on tumor epithelial-mesenchymal transition.Screening of Target Genes and Regulatory Function of miRNAs as Prognostic Indicators for Prostate Cancer.Methylation and microRNA-mediated epigenetic regulation of SOCS3.Modulation of microRNAs by phytochemicals in cancer: underlying mechanisms and translational significance.Molecular markers for prostate cancer in formalin-fixed paraffin-embedded tissues.MicroRNAs and complex diseases: from experimental results to computational models.Apoptosis induction of colorectal cancer cells HTL-9 in vitro by the transformed products of soybean isoflavones by Ganoderma lucidum.MiR-29a: a potential therapeutic target and promising biomarker in tumors.miRNA in tumour metabolism and why could it be the preferred pathway for energy reprograming.MiR-1256 suppresses proliferation and migration of non-small cell lung cancer via regulating TCTN1.

P2860

Q21129296-86C9AE51-C728-49F4-B786-2CF495F5A436 Q26782613-F43EA5D0-657C-4646-8CAE-BD7CF8987E89 Q27016123-9F9CE273-AE39-4C8E-BDA5-5053F61D86DB Q33586833-4963824A-4039-4017-8173-1ABAE572FEE3 Q33787995-E268ABED-AFF2-48EB-BBDA-015FAFB79EB1 Q33812463-65B198FA-F8AD-4117-AD69-32C67246594E Q34411665-34E8E3C6-7906-4AC6-A042-5842819DB228 Q34582580-F0D9F3DD-002C-4E59-B980-EEA84FB6AA6A Q34690409-B201E483-E624-48F9-8F87-A807E2938210 Q34940543-CCC0043D-5787-4E78-9FCB-E8CC10A0A420 Q35131323-404181D0-6CB0-4AAC-9B32-5B18A00C2F19 Q35202274-B3024CFF-0DAD-4AA2-856C-924F23C3836C Q35794952-3EE4C4C7-4A0D-478E-B3E2-451D31FADF4B Q37108220-8CF4E630-A590-4DEA-A115-6CE20C188BB6 Q37207772-82E0FFDF-1B13-4E7B-B52E-309AF5AD6D84 Q37654590-12C92AB2-B17E-41CE-9AEA-2336640A67C1 Q37719054-3BFCC829-15F6-4F02-9E72-7DC55213F9C3 Q37727814-B5F03D29-7DDF-4F39-8C46-5D7108B0CA80 Q38096240-EFC69D58-FBED-4324-8884-22FECA202D38 Q38169189-238D26E4-0F9E-4ADA-A05E-66CE460347E5 Q38212471-A2243587-F961-481F-9B93-4E0690AEDF7F Q38707912-797ADF5E-8B56-415C-B259-8E882BB94AF4 Q38770659-7328F096-D884-4925-8B6F-43D6E53E3D99 Q38816103-85DE5351-EF30-49B1-A540-6CC57DAC9DF5 Q38826614-A4E3A16B-F0DD-45A5-A128-544F5C960485 Q38971323-6F1321C9-0FBA-43B7-A1E5-2DC8991EAFF5 Q39030478-72A79F10-0656-4167-BEE0-79033960A2F3 Q39103785-B7A20FDE-A3B0-4A9C-87FB-F3EA66571434 Q39220695-24579BFF-3667-4801-8FF5-9B3AC4B0E294 Q39443955-D40EDC90-05EA-4A57-AAAE-DEA0ACE2E9E3 Q39458257-04C36C14-B258-4710-877A-7CCDC345F0D1 Q40251268-2C803EF2-0A52-48DB-A24D-91E3195F4041 Q41240274-CA2877E1-45C6-499A-AB79-4691290D3DE7 Q42180647-6402EF4B-E905-4472-8173-DBAA6346D7B4 Q42184292-A12EB157-62A8-4696-9040-1500210982C6 Q45944835-B3FEBFBE-7ED1-4E0C-A36F-BA29EFC84BE1 Q47284384-755A8564-2F50-4416-89B8-F80CBEFB6FA2 Q47568135-938B1972-D0E5-4F1A-BAFF-A3BAC0AE07F4 Q50064930-1E7E8830-15C4-480E-8AB6-14A6DDEB6210 Q55632252-5A60C7BB-6A89-416F-A40C-DB9A0771AF52

P2860

Epigenetic deregulation of miR-29a and miR-1256 by isoflavone contributes to the inhibition of prostate cancer cell growth and invasion

http://www.wikidata.org/entity/Q36187865

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@ast

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@en

type

label

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@ast

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@en

prefLabel

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@ast

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@en

P1433

Q36187865-BB0C6003-EA5A-4069-91A5-5745FEFF640B

P1476

Q36187865-88849941-91C5-421D-A2F2-1B351FC291A8

P2093

Q36187865-14EB216B-9B0E-41D9-BD52-1B2DCB596DD4

Q36187865-1D458DE7-9A38-4491-864F-5EB546294B62

Q36187865-660EB7B3-17F1-4FE5-AA27-0005F091F99B

Q36187865-8022C7B9-8AD5-4DDE-8683-4B3E4D5987C7

Q36187865-8FDE27B3-DD82-4B16-ABFA-177F9C8D431A

Q36187865-97369CE5-A697-470E-BE02-4FE3B0659D61

P2860

Q36187865-0507A67C-ADFE-4241-8086-A3809407BA61

Q36187865-05BA2E6C-8881-4079-8859-903C9503EB35

Q36187865-0AC86707-BE91-4AC2-84B7-E1B97754E687

Q36187865-174421FC-036E-4289-A75D-E904D226EC7E

Q36187865-180B5E8D-DA18-4E55-B804-93392FC4DE61

Q36187865-1BF35CD5-EE4C-4409-9052-34B1E24C932B

Q36187865-1C151DD5-6D79-4264-9F5E-D093DABB4D63

Q36187865-26DE0D0B-39CA-4727-9482-51D710AF4117

Q36187865-2D9A0B7C-865D-40EB-9D17-39A947C8164F

Q36187865-376F5E5A-EDC8-4283-B7AA-5639DF144E47

P304

Q36187865-07BEAB25-A43D-44E2-AB5E-01587A984FFA

P31

Q36187865-BC5C74FD-A09E-4372-B139-04A91BE90FBF

P356

Q36187865-76BB77B6-7114-44C7-8B0A-856B5F341E86

P433

Q36187865-362025CF-FE2F-4AA7-800D-A93E665A9D81

P478

Q36187865-C4345B12-21D1-4643-98DA-DED7A7D83630

P50

Q36187865-906922C1-BF20-4800-AC7E-8FAA719FC1B4

P577

Q36187865-C3AD32BC-83C1-42F9-82FB-6D1A3C39E5DD

P698

Q36187865-A57C15D6-0D44-4162-9310-3311CEC8966D

P932

Q36187865-EAA930B5-AB82-45DE-B819-FB42E8321202

P356

P1433

P1476

Epigenetic deregulation of miR ...... ancer cell growth and invasion

@en

P2093

Aamir Ahmad

http://www.w3.org/2001/XMLSchema#string

Bin Bao

http://www.w3.org/2001/XMLSchema#string

Dejuan Kong

http://www.w3.org/2001/XMLSchema#string

Fazlul H Sarkar

http://www.w3.org/2001/XMLSchema#string

Gregory Dyson

http://www.w3.org/2001/XMLSchema#string

Yiwei Li

http://www.w3.org/2001/XMLSchema#string

P2860

TRIM68 regulates ligand-dependent transcription of androgen receptor in prostate cancer cells

The functional significance of microRNA-145 in prostate cancer

Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells

Cancer statistics, 2012

Tumor suppressor BRCA1 epigenetically controls oncogenic microRNA-155

miR-146a suppresses invasion of pancreatic cancer cells

Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype.

MiR-29a inhibits cell proliferation and induces cell cycle arrest through the downregulation of p42.3 in human gastric cancer

Characterization of phosphoglycerate kinase-1 expression of stromal cells derived from tumor microenvironment in prostate cancer progression.

A novel function for vimentin: the potential biomarker for predicting melanoma hematogenous metastasis.

P304

940-949

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4161/EPI.21236

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Fazlul H. Sarkar

P577

2012-07-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22805767

http://www.w3.org/2001/XMLSchema#string

P932

3427289

http://www.w3.org/2001/XMLSchema#string